0000915389-26-000013
SEC filingEastman Chemical Company reported fiscal year 2025 results with $8.75 billion in sales, generating $1.84 billion in gross profit and $474.0 million in net earnings attributable to Eastman. The company achieved $776.0 million in earnings before interest and taxes (EBIT) and $568.0 million in earnings before income taxes. Operating cash flow was strong at $970.0 million, supporting $546.0 million in capital expenditures and $381.0 million in dividends paid to stockholders. The balance sheet shows $14.86 billion in total assets with $8.82 billion in total liabilities, resulting in $6.04 billion in total equity. The company maintained $493.0 million in cash and cash equivalents at year-end. No prior year comparison figures are provided in the source data for year-over-year analysis.
Eastman Chemical Company reported fiscal year 2025 financial results with $8.75 billion in sales, representing the company's top-line performance for the period. The company generated $1.84 billion in gross profit, resulting in a 21.0% gross margin. Operating performance yielded $776.0 million in earnings before interest and taxes (EBIT), with net earnings attributable to Eastman reaching $474.0 million. Basic earnings per share stood at $4.00. Comprehensive income attributable to Eastman totaled $628.0 million, including $154.0 million in other comprehensive income. The company's cash generation was robust, with $970.0 million in net cash provided by operating activities. No prior year comparison figures are provided in the source data for year-over-year analysis.
The source data provides consolidated revenue of $8.75 billion for fiscal year 2025 without segment breakdown or geographic mix details. The document does not disclose specific segment performance, revenue drivers by product line, or geographic distribution of sales. Cost of sales totaled $6.91 billion, representing 79.0% of revenue. The company's revenue generation supported significant operating activities and capital allocation decisions throughout the fiscal year. Without segment disclosure in the provided data, detailed revenue analysis by business unit or geographic region cannot be performed.
Gross margin for fiscal year 2025 was 21.0%, calculated from $1.84 billion gross profit on $8.75 billion sales. Operating margin was 8.9%, derived from $776.0 million EBIT on $8.75 billion sales. The company incurred $658.0 million in selling, general and administrative expenses (7.5% of sales) and $255.0 million in research and development expenses (2.9% of sales). Asset impairments, restructuring, and other charges totaled $96.0 million. Other income components provided $84.0 million in benefits, while post-employment benefit costs showed a $25.0 million benefit. Net interest expense was $208.0 million, and provision for income taxes was $93.0 million, resulting in an effective tax rate of 16.4%.
Operating activities generated $970.0 million in cash, with adjustments including $513.0 million in depreciation and amortization and $141.0 million in deferred tax provisions. Working capital changes included a $61.0 million increase in trade receivables and a $24.0 million increase in inventories. Investing activities used $462.0 million, primarily for $546.0 million in property and equipment additions, partially offset by $21.0 million in government incentives and $38.0 million from business sales. Financing activities used $797.0 million, including $550.0 million in debt repayments, $381.0 million in dividends, and $100.0 million in treasury stock purchases. Free cash flow (operating cash flow minus capital expenditures) was $424.0 million. The balance sheet shows $14.86 billion in total assets with $3.65 billion in current assets and $5.73 billion in net properties. Total liabilities were $8.82 billion, including $4.20 billion in long-term borrowings. Total equity was $6.04 billion, with $5.96 billion attributable to Eastman stockholders.
The source data does not contain management guidance, strategic priorities, or specific risk factor disclosures that would typically appear in the Management's Discussion and Analysis or Risk Factors sections of a 10-K filing. The provided financial statements and XBRL data focus exclusively on historical financial results for fiscal year 2025 without forward-looking statements, projections, or qualitative assessments of future performance. Investors would need to consult the complete 10-K filing document for information on management's outlook, strategic initiatives, market conditions, competitive positioning, regulatory environment, or other factors that might affect future performance.